Explore the words cloud of the LiST project. It provides you a very rough idea of what is the project "LiST" about.
The following table provides information about the project.
|Coordinator Country||Italy [IT]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2017-02-01 to 2017-05-31|
Take a look of project's partnership.
'Decision making in Life Science and Healthcare sector (LSH) is mainly based on laboratory tests results; errors result in up to €27.3B worth of economic damage globally or can have devastating effect such as loss of lives. Automation of laboratory operations is a one-way street for LSH laboratories in order to deal with the high volume of tests demanded and provide fast and accurate results; however, the solutions suggested should also meet their tight budgets.
The objective of LiST project, which is currently positioned at TRL6, is to bring into the market a variety of cost-effective automated laboratory equipment (LiST products) all based on a common robotic platform (List platform). The innovative List platform will be able to fit different groups of specific parts (LiST tools), with each group/tool designed to perform a single application related to sample handling (SH) before or after sample storage. SH applications include basic but time- and manpower-consuming tasks that, if automated, can considerably increase laboratories' productivity and efficiency. The use of an 'one-for-all' platform will reduce development costs by 60% (€160K vs. current €200-500K - only the development of the specific tools will be required) and will help us provide our customers with 15% cheaper (€9,000 vs. current €11,000) automated equipment in less time (time-to-market 6-12 vs. 24 months).
HTA is a leading Italian engineering and manufacturing company in the business of scientific instrumentation to laboratories, since 25 years. Having already successfully established 'one-for-all' robotic platforms in the analytical market we are now confident that the same business plan would triumph in a rapidly developing and open to automation market like LSH. The total investment of LiST is €1.15M and the average profit gain will be €0.95M/year thus the pay back of the project will be only 1.2 years after its commercialization. '
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIST" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LIST" are provided by the European Opendata Portal: CORDIS opendata.
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
ENDOSCAPE, a clinically applicable non-viral gene delivery technologyRead More